Leadership

Ronald J. Zenk, MBA

Chief Executive Officer

Michael D. Kaytor, Ph.D.

Chief Scientific Officer

Rear Admiral Colin Chinn, MD, MHS, FACP

Chief Medical Officer

Timothy E. Morris

Chief Operating Officer

Artur Serebrenik, Ph.D.

Director of Product Development

Ronald J. Zenk, MBA

Chief Executive Officer

Timothy E. Morris

Chief Operating Officer

John C. Dykstra

Mr. Dykstra has served as a member of the Board since 1999.

Barbara R. Holcomb, RN, BSN, MSN

General Holcomb has served as a member of the Board since 2023.

Thomas F. Jasper

Mr. Jasper has served as a member of the Board since 2022.

Robert C. Miller, MD

Professor of Radiation Oncology, University of Maryland School of Medicine

Dr. Miller is a practicing radiation oncologist within the University of Maryland School of Medicine and is the Medical Director of the Maryland Proton Treatment Center.

Douglas W. Bryce

Advisor - CBRN Medical Countermeasure Contracting.

Mr. Bryce served as the Joint Program Executive Officer, Chemical, Biological, Radiological and Nuclear Defense.

Isabel L. Jackson, Ph.D.

Assistant Professor of Radiation Oncology, University of Maryland

Dr. Jackson's area of expertise is focused on understanding the mechanisms underlying radiation effects in tissue.

Michael R. Landauer, Ph.D.

Scientist Emeritus, Armed Forces Radiobiology Research Institute

Dr. Landauer is a radiation countermeasure consultant.